AntidiabeticsSUBCUTANEOUSStandard

HUMULIN R KWIKPEN

INSULIN HUMAN

Standard Dose

1500 UNITS/3ML (500 UNITS/ML)

Max Dose

Refer to approved labeling

Primary Use

Label for HUMULIN R U-100 Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview HUMULIN R KWIKPEN is listed in Drugs@FDA under application 018780 (BLA).

Label for HUMULIN R U-100 Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN HUMAN Form and strength SOLUTION;SUBCUTANEOUS - 1500 UNITS/3ML (500 UNITS/ML) Sponsor LILLY Submission history Latest submission status date: 2022-06-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview HUMULIN R KWIKPEN is listed in Drugs@FDA under application 018780 (BLA). Label for HUMULIN R U-100 Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN HUMAN Form and strength SOLUTION;SUBCUTANEOUS - 1500 UNITS/3ML (500 UNITS/ML) Sponsor LILLY Submission history Latest submission status date: 2022-06-27 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.